Latest Medulloblastoma Stories
The Hedgehog signaling pathway is involved in a preliminary study and case report describing positive responses to an experimental anticancer drug in a majority of people with advanced or metastatic basal cell skin cancers. One patient with the most common type of pediatric brain cancer, medulloblastoma, also showed tumor shrinkage.
A discovery in Canada could help more children survive brain cancer.
Canadian scientists say they've discovered eight similar genes that, when mutated, appear to cause medulloblastoma -- a common childhood brain cancer. This discovery is very promising and may help researchers develop better, more targeted treatments so that more of these children will survive and fewer will suffer debilitating side effects, said Christine Williams, director of research programs for the Canadian Cancer Society Research Institute. The study was led by Dr.
Researchers funded by the Canadian Cancer Society have discovered eight similar genes that, when mutated, appear to be responsible for medulloblastoma â€“ the most common of childhood brain cancers. The findings are published yesterday in the online edition of the journal Nature Genetics.
By Valle, Luis Del White, Martyn K; Khalili, Kamel Abstract The human polyomavirus JC (JCV) is a small DNA tumor virus and the etiologic agent of the progressive multifocal leukoencephalopathy.
M. D. Anderson team connects REST to regenerative medicine, pediatric brain cancer
By Takei, Hidehiro; Bhattacharjee, Meenakshi B; Rivera, Andreana; Dancer, Yeongju; Powell, Suzanne Z * Context.-Immunohistochemistry (IHC) has become an important tool in the diagnosis of brain tumors. Objective.-To review the latest advances in IHC in the diagnostic neuro-oncologic pathology.
By Megan Rauscher NEW YORK (Reuters Health) - Findings from a new study suggest that a father's exposure to heat -- saunas, for example -- just before his partner becomes pregnant may increase the risk of brain tumors occurring in their offspring.
By David Douglas NEW YORK (Reuters Health) - Hearing loss appears to be a significant and under-reported side effect of platinum-based drugs used to treat a variety of childhood cancers, according to researchers. As senior investigator Dr. Edward A.
By Will Boggs, MD NEW YORK (Reuters Health) - Hearing loss may be more common than previously reported in children with cancer who have undergone chemotherapy with highly effective platinum-type drugs such as cisplatin and carboplatin, researchers report.